Neuroimaging in the context of examining atypical parkinsonian tauopathies is an evolving matter. Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) bring tools, which may be reasonable in supplementary examination, however cannot be interpreted as a gold standard for correct diagnosis. The review presents advantages and limitations of tau radiotracers in PET, metabolic PET and perfusion SPECT. The aim of this paper is to highlight the possibilities and boundaries in the supplementary examination of tauopathic parkinsonian syndromes
PSP is a pathologically defined neurodegenerative tauopathy with a variety of clinical presentations...
Parkinsonian symptoms are associated with a number of neurodegenerative disorders, such as Parkinson...
Atypical parkinsonisms (APs) are a group of diseases linked to tau pathology. These include progress...
Background: F-18-fluordeoxyglucose positron emission tomography (FDG-PET) is widely used for discrim...
Tau PET in Parkinson syndromes. A new diagnostic tool?Jochen Hammes,1 Gérard Bischof,1,2 Kathrin Gie...
[Objective] We aim to establish a diagnostic system for progressive supranuclear palsy (PSP) by tau ...
Background: F-18-fluordeoxyglucose positron emission tomography (FDG-PET) is widely used for discrim...
PSP is a neurodegenerative movement disorder that is characterized by the pathological accumulation ...
In recent years, several radiotracers that selectively bind to pathological tau proteins have been d...
Purpose of Review Abnormal accumulation of tau protein is the main hallmark of tauopathies and is cl...
PSP is a pathologically defined neurodegenerative tauopathy with a variety of clinical presentations...
Purpose Early after [F-18]PI-2620 PET tracer administration, perfusion imaging has potential for reg...
Progressive supranuclear palsy (PSP) is a neurodegenerative movement disorder characterized by depos...
BACKGROUND: Accumulation of cortical and subcortical tau pathology is the primary pathological subst...
Corticobasal Degeneration Degeneration (CBD) and Progressive Supranuclear Palsy (PSP) are types of f...
PSP is a pathologically defined neurodegenerative tauopathy with a variety of clinical presentations...
Parkinsonian symptoms are associated with a number of neurodegenerative disorders, such as Parkinson...
Atypical parkinsonisms (APs) are a group of diseases linked to tau pathology. These include progress...
Background: F-18-fluordeoxyglucose positron emission tomography (FDG-PET) is widely used for discrim...
Tau PET in Parkinson syndromes. A new diagnostic tool?Jochen Hammes,1 Gérard Bischof,1,2 Kathrin Gie...
[Objective] We aim to establish a diagnostic system for progressive supranuclear palsy (PSP) by tau ...
Background: F-18-fluordeoxyglucose positron emission tomography (FDG-PET) is widely used for discrim...
PSP is a neurodegenerative movement disorder that is characterized by the pathological accumulation ...
In recent years, several radiotracers that selectively bind to pathological tau proteins have been d...
Purpose of Review Abnormal accumulation of tau protein is the main hallmark of tauopathies and is cl...
PSP is a pathologically defined neurodegenerative tauopathy with a variety of clinical presentations...
Purpose Early after [F-18]PI-2620 PET tracer administration, perfusion imaging has potential for reg...
Progressive supranuclear palsy (PSP) is a neurodegenerative movement disorder characterized by depos...
BACKGROUND: Accumulation of cortical and subcortical tau pathology is the primary pathological subst...
Corticobasal Degeneration Degeneration (CBD) and Progressive Supranuclear Palsy (PSP) are types of f...
PSP is a pathologically defined neurodegenerative tauopathy with a variety of clinical presentations...
Parkinsonian symptoms are associated with a number of neurodegenerative disorders, such as Parkinson...
Atypical parkinsonisms (APs) are a group of diseases linked to tau pathology. These include progress...